Kala Pharmaceuticals Adds 6% In Morning Trade

On:

Shares of Kala Pharmaceuticals, Inc. (KALA) are rising more than 6% Friday morning at $16.43.

The company today said Combangio, Inc., a unit of Kala, has been awarded a $15 million grant by the California Institute for Regenerative Medicine (CIRM) to support the company’s ongoing study of KPI-012 for the treatment of persistent corneal epithelial defect (PCED).

KALA has traded in the range of $3.54-$56.72 in the last 1 year.

Source: Read Full Article

Lates News:
  1. Kala Pharmaceuticals Ascends 5% On Getting Fast Track Designation For Its KPI-012
  2. Cryptos Muted Amidst Anxiety Over FTX Ramifications
  3. Weibo Shares Drop After Pricing ADS Offering
  4. Rate Hike Fears Dampen Market Sentiment
  5. Palo Alto Networks Shares Rise On Improved Q4 Results, Outlook